HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CIR May Reopen File On Human Umbilical Extract With Products In Pipeline

This article was originally published in The Rose Sheet

Executive Summary

A Las Vegas company's intent to use human umbilical extract in skin-care products may prompt the Cosmetic Ingredient Review Expert Panel to reopen a safety assessment of the ingredient.

You may also be interested in...



Novo Solutions Launches Skin Care with Human Umbilical Cord Serum

Novo Solutions MD claims that its NovoSerum, derived from purified human umbilical cord blood, will “stop, slow and reverse skin damage” in 30 days.

CIR Affirms Triclosan Safety, Opts For Formaldehyde Re-Review

The Cosmetic Ingredient Review Expert Panel tackled a number of controversial issues at its Dec. 13-14 meeting in Washington.

CIR Affirms Triclosan Safety, Opts For Formaldehyde Re-Review

The Cosmetic Ingredient Review Expert Panel tackled a number of controversial issues at its Dec. 13-14 meeting in Washington.

Related Content

UsernamePublicRestriction

Register

RS017340

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel